$0.84
+0.10 (+13.16%)
Open$0.77
Previous Close$0.74
Day High$0.84
Day Low$0.74
52W High$5.50
52W Low$0.62
Volume—
Avg Volume5.88M
Market Cap39.28M
P/E Ratio—
EPS$-1.78
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+1,619.4% upside
Current
$0.84
$0.84
Target
$14.46
$14.46
$8.98
$14.46 avg
$17.59
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 18.60M | 19.31M | 20.88M |
| Net Income | -5,133,777 | -5,587,628 | -4,631,912 |
| Profit Margin | -27.6% | -28.9% | -22.2% |
| EBITDA | -5,451,350 | -5,303,939 | -6,015,367 |
| Free Cash Flow | -4,165,501 | -4,081,500 | -5,685,079 |
| Rev Growth | +22.8% | -8.3% | +12.1% |
| Debt/Equity | 0.56 | 0.49 | 0.59 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $286.01 | -2.33% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $443.89 | -3.07% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.98 | -0.75% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $536.45 | +0.42% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $945.53 | -1.28% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $149.40 | -4.54% | 7.7 | 20.98B |